Prevent Cancer Foundation Blog

Yesterday, the US Food and Drug Administration (FDA) took action to move cancer prevention forward with the approval of a vaccine for prevention of anal cancer and anal intraepithelialneoplasia (AIN) due to human papillomavirus (HPV) types 6, 11, 16, and 18 in males and females ages 9 to 26. The vaccine has been approved previously in other indications, for the prevention of cervical, vulvar and vaginal cancer in women of the same age range. Incidence of ...

Anna R Giuliano, PhD Director of Cancer Prevention H. Lee Moffitt Cancer Center  In 1991, I was a young scientist who received my first research grant from the Prevent Cancer Foundation for my study of the human papillomavirus (HPV).  This award enabled me to establish the methodology for measuring the HPV DNA infection.  The lessons learned gave me the ability to propose and develop the trials of the first FDA-approved vaccine against HPV, the one you’ve heard so ...

Reaching out to individuals in soup kitchens, at health fairs and through local radio Programs, the Prevent Cancer Foundation’s community grantees are making a difference in rural and urban communities. Facing limited resources and large undeserved populations, the five community grantees have made a tremendous impact in their communities by providing valuable cancer prevention education and screening services. Here is a snapshot of the Foundation’s community grant work: Chenango health Network, Chenango County, Ny— The Chenango ...